Martínez F, Lefèvre J P, Kowalski A. "Method for the Synthesis of 1-(4-Chlorophenyl)-3-(4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl)pyridazin-4(1H)-one" [P]. European Patent, EP 3590896 A1, 2016-05-22.
发明人沈红梅,朱建伟,唐晓军. "A Process for Preparing High-Purity 1-(4-Chlorophenyl)-3-(4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl)pyridazin-4(1H)-one" [P]. 中国发明专利, 专利号 CN 111426321 A, 授权公告日 2024-06-14.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2011, 974, (5), 1956-1978.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2017, 778, 9153-9169.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-Chlorophenyl)-3-(4-ethyl-5-(methylthio)-4H-1,2,4-triazol-3-yl)pyridazin-4(1H)-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 417, (12), 5486-5515.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2020, 195, 5258-5273.